Vol 2, No 4 (2017)
Original article
Published online: 2018-03-30

open access

Page views 1195
Article views/downloads 922
Get Citation

Connect on Social Media

Connect on Social Media

Knowledge about health and disease in obese patients after myocardial infarction. An observational study

Łukasz Pietrzykowski, Piotr Michalski, Agata Kosobucka, Michał Kasprzak, Aldona Kubica
Medical Research Journal 2017;2(4):135-140.

Abstract

Introduction. Conscious implementation of a therapeutic plan immediately after discharge from hospital is pivotal in myocardial infarction survivors. Obesity and overweight are known as factors increasing the risk of adverse cardiovascular events and worsening long-term clinical outcome. The aim of the study was to assess the knowledge regarding cardiovascular diseases in patients with myocardial infarction undergoing in-hospital brochure-based education in relation to the prevalence of overweight and obesity. Patients and methods. A prospective, single-centre, cohort, observational study was conducted in 228 patients hospitalised due to myocardial infarction (women n = 52, men n = 176). A dedicated questionnaire containing 20 single-choice questions was applied for the knowledge assessment. Patients were divided into three groups depending on the BMI level (normal, overweight, obesity). Results. Comparison of patients’ knowledge at baseline and on the day of discharge revealed a significant increase of overall result (p = 0.0264) and of knowledge about prophylaxis (p = 0.0115). Multivariate analysis showed education level (-5.82 ± 2.576, p = 0.025) and BMI (-4.54 ± 1.771, p = 0.011) as independent factors determining the overall increase in patients’ knowledge. Conclusions. Educational interventions in overweight and obese patients should be intensified. The brochure is an effective educational tool.

Article available in PDF format

View PDF Download PDF file

References

  1. World Health Organization The challenge of obesity in the WHO European Region. Fact sheet EURO 2005;13:1-4. http://www.euro.who.int/__data/assets/pdf_file/0018/102384/fs1305e.pdf (2005).
  2. Finucane MM, Stevens GA, Cowan MJ, et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011; 377(9765): 557–567.
  3. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945): 766–781.
  4. Kasprzak M, Molska M, Obońska K, et al. Variability of prasugrel antiplatelet effect in patients with acute coronary syndrome. Medical Research Journal. 2015; 3(3): 117–124.
  5. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The Lancet. 2009; 373(9669): 1083–1096.
  6. Räikkönen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism. 2002; 51(12): 1573–1577.
  7. Benito-León J, Mitchell AJ, Hernández-Gallego J, et al. Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol. 2013; 20(6): 899–906, e76-7.
  8. Piepoli MF, Hoes AW, Agewall S, et al. ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29): 2315–2381.
  9. Kubica A. Broszura - narzędzie edukacji zdrowotnej w kardiologii. Przyczynek do dyskusji o skuteczności profilaktyki wtórnej. Folia Cardiologica Excerpta. 2008; 3: 441.
  10. Kubica A, Grześk G, Sinkiewicz W, et al. Compliance, concordance, adherence in chronic therapy. Folia Cardiol Excerpta. 2010; 5: 54–57.
  11. Kubica A. Współpraca z pacjentem – podstawowy warunek skuteczności terapii w chorobie wieńcowej. Choroby Serca i Naczyń. 2009; 6: 131.
  12. Kubica A. Psychologiczny aspekt zawału serca — niedoceniana zmienna w procesie terapii i rehabilitacji. Folia Cardiologica Excerpta. 2009; 4: 197.
  13. Smuclovisky C. Coronary Artery Disease. Coronary Artery CTA. 2009: 33–67.
  14. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promotion International. 2000; 15(3): 259–267.
  15. Kubica A, Magielski P, Olejarczyk E, et al. Źródła wiedzy a skuteczność edukacji u osób z ostrym zawałem serca. Folia Cardiologica. 2009; 4(5): 285–290.
  16. Michalski P, Kosobucka A, Pietrzykowski Ł, et al. Knowledge and learning preferences of patients with myocardial infarction. Med Res J. 2016; 1(4): 120–124.
  17. Kubica A, Pufal J, Moczulska B, et al. Ocena wiedzy dotyczącej profilaktyki i objawów choroby niedokrwiennej serca u osób hospitalizowanych w klinice kardiologii. Psychiatr w Prakt Ogólnolek. 2004; 4: 135.
  18. Kubica A, Pufal J, Moczulska B, et al. Skuteczność edukacji zdrowotnej u osób hospitalizowanych w klinice kardiologii. Psychiat w Prakt Ogólnolek. 2005; 5: 61.
  19. Kubica A, Obońska K, Fabiszak T, et al. Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials. Curr Med Res Opin. 2016; 32(8): 1441–1451.
  20. Di Chiara T, Scaglione A, Corrao S, et al. Association between low education and higher global cardiovascular risk. J Clin Hypertens (Greenwich). 2015; 17(5): 332–337.
  21. Giardina EGV, Mull L, Sciacca RR, et al. Relationship between cardiovascular disease knowledge and race/ethnicity, education, and weight status. Clin Cardiol. 2012; 35(1): 43–48.
  22. Cournot M, Marquié JC, Ansiau D, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology. 2006; 67(7): 1208–1214.
  23. Jaracz M, Bieliński M, Junik R, et al. Zaburzenia pamięci operacyjnej, funkcji wykonawczych i objawy depresji u osób z patologiczną otyłością. Psychiatria. 2009; 6(1): 9–14.
  24. Cserjési R, Luminet O, Poncelet AS, et al. Altered executive function in obesity. Exploration of the role of affective states on cognitive abilities. Appetite. 2009; 52(2): 535–539.
  25. Koszowska A, Dittfeld A, Zubelewicz-Szkodzińska B. Psychologiczny aspekt odżywiania oraz wpływ wybranych substancji na zachowania i procesy myślowe. Hygeia Public Health. 2013; 48(3): 279–284.
  26. Gomez-Pinilla F. The combined effects of exercise and foods in preventing neurological and cognitive disorders. Prev Med. 2011; 52 Suppl 1: S75–S80.
  27. Alosco ML, Spitznagel MB, Gunstad J. Obesity as a risk factor for poor neurocognitive outcomes in older adults with heart failure. Heart Fail Rev. 2014; 19(3): 403–411.
  28. Kubica A, Kasprzak M, Obońska K, et al. Impact of health education on adherence to clopidogrel and clinical effectiveness of antiplatelet treatment in patients after myocardial infarction. Med Res J. 2016; 3(4): 154–159.
  29. Kubica J, Adamski P, Buszko K, et al. Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study. Eur Heart J Cardiovasc Pharmacother. 2017 [Epub ahead of print].
  30. Kubica A, Sinkiewicz W, Szymański P, et al. Edukacja zdrowotna w chorobach układu krążenia – możliwości i zagrożenia. Folia Cardiol Excerp. 2007; 2: 177.
  31. Kubica A. Wybrane problemy prewencji wtórnej u chorych po incydentach wieńcowych. Folia Cardiol Excerp. 2008; 3: 366.
  32. Kubica A, Kasprzak M, Obońska K, et al. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. Pharmacology. 2015; 95(1-2): 50–58.